U.S. stock indexes are slipping following the latest discouraging signal on the U.S. economy. The S&P 500 fell 0.4% Tuesday, ...

Bottom line: Palantir continues to benefit from investor activity that is pricing the future, not the current P/E ratio into ...

Clients of BofA Securities last week bought cyclical stocks at the fastest pace in years, according to a weekly report from a ...

U.S. stocks rallied and won back most of their sharp loss from last week. The S&P 500 jumped 1.5% Monday to follow up its ...

The latest meme stock mania may have faded, but retail investors are always looking out for the next short-squeeze. Data from ...

Asian equities had a strong day, led by Australia, South Korea, Taiwan, Thailand, and Vietnam, while India underperformed, as ...

Prudent pricing, exposure growth, solid retention, renewals, and improved digitalization are expected to help AIG, MFC, and ...

Global stocks rose for a second session on Tuesday and the U.S. dollar steadied as investors raised bets the Federal Reserve ...

ASP Isotopes, a cutting edge player in nuclear and quantum materials, has surged an impressive 107% so far in 2025. The ...

Discover the five best-performing blue chip stocks of 2025 so far. See which stocks are driving returns for investors this ...

U.S. stocks have stumbled since the start of August, and a number of Wall Street strategists are warning that this might be ...

Palantir rose after earnings blew past Wall Street estimates, while shares of Vertex Pharmaceuticals and Hims & Hers ...